검색
Ascendis Pharma A/S
ASND관심 목록에 추가
243.910USD
-7.160-2.85%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
15.12B시가총액
35.15P/E TTM
자세한 내용은 Ascendis Pharma A/S 회사
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ascendis Pharma A/S 정보
종목 코드 ASND
회사 이름Ascendis Pharma A/S
상장일Jan 28, 2015
CEOMoller Mikkelsen (Jan)
직원 수- -
유형Depository Receipt
회계 연도 종료Jan 28
주소Tuborg Boulevard 12
도시HELLERUP
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Denmark
우편 번호2900
전화4570222244
웹사이트https://ascendispharma.dk/
종목 코드 ASND
상장일Jan 28, 2015
CEOMoller Mikkelsen (Jan)
Ascendis Pharma A/S의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Mr. Jan Moller Mikkelsen
Mr. Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
President, Chief Executive Officer, Executive Director, Member of the Executive Board
--
--
Ms. Lotte Soenderbjerg
Ms. Lotte Soenderbjerg
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
--
--
Dr. Kennett Sprogoee, Ph.D.
Dr. Kennett Sprogoee, Ph.D.
Executive Vice President, Head of Innovation and Research
Executive Vice President, Head of Innovation and Research
--
--
Mr. Scott T. Smith
Mr. Scott T. Smith
Chief Financial Officer, Executive Vice President, Member of the Executive Board
Chief Financial Officer, Executive Vice President, Member of the Executive Board
--
--
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
--
-100.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Mr. Jan Moller Mikkelsen
Mr. Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
President, Chief Executive Officer, Executive Director, Member of the Executive Board
--
--
자주 묻는 질문
Ascendis Pharma A/S의 상위 5대 주주는 누구인가요?
Ascendis Pharma A/S의 상위 5대 주주는 다음과 같습니다: Mr. Flemming Steen Jensen
Ascendis Pharma A/S(ASND)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Ascendis Pharma A/S의 주식을 보유한 기관은 총 582곳이며, 이들이 보유한 주식의 총 가치는 약 69.20M로 전체 발행 주식의 111.42%를 차지합니다. 이는 2025Q4 대비 -1676383.00 증가한 수치입니다.
Ascendis Pharma A/S의 최대 수익원은 무엇인가요?
2026Q1 기준, Ascendis Pharma A/S의 Commercial sale of products 부문이 가장 높은 매출을 기록했으며, 금액은 683.57M로 전체 매출의 94.92%를 차지했습니다.